2. Patients and Methods
2.1 Patients
Fifty-nine patients with HCC diagnosed in our hospital from July 2016 to
June 2019 were enrolled (Table 1). All patients were confirmed as HCC by
two or more imaging examinations or liver tumor biopsy, according to the
Expert Consensus on Regulation of Standardized Diagnosis and Treatment
of Primary Liver Cancer. Twenty-eight patients were followed up
regularly after GSMs -TACE treatment for 30 days and the Treg cells
proportion in peripheral blood was examined (Fig. 1, Table 2). Ten
healthy volunteers were selected as control group.
Table 1 Characteristics of 59 patients with HCC